Ogivri for Breast Cancer, Metastatic User Reviews
Ogivri has no reviews submitted for this condition. Be the first to review this drug.
Learn more about Breast Cancer, Metastatic
Care guides
More about Ogivri (trastuzumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Patient resources
- Ogivri drug information
- Ogivri (Trastuzumab Intravenous) (Advanced Reading)
- Ogivri (Trastuzumab-dkst Intravenous) (Advanced Reading)
Other brands
Herceptin, Trazimera, Kanjinti, Ontruzant, ... +2 more
Professional resources
Other brands
Herceptin, Trazimera, Kanjinti, Ontruzant, Herzuma
